Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.
about
Molecular Mechanisms to Control Post-Transplantation Hepatitis B RecurrenceHepatitis B precore protein: pathogenic potential and therapeutic promiseMolecular mechanisms underlying occult hepatitis B virus infection.Contradictory immune response in post liver transplantation hepatitis B and C.Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingShort-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B.Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals.Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infectionModeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity.Safe and cost-effective control of post-transplantation recurrence of hepatitis B.Smaller reduction of hepatitis B virus DNA in liver tissue than in serum in patients losing HBeAg.A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal.Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.A potent human neutralizing antibody Fc-dependently reduces established HBV infectionsIn Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy.High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients.Pathogen and autoantigen homologous regions within the cystic fibrosis transmembrane conductance regulator (CFTR) protein suggest an autoimmune treatable component of cystic fibrosis.Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics.Respiratory syncytial virus vaccine developmentHBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
P2860
Q26799246-A8400560-F330-45A3-AA01-2A77A5FFB33FQ26824158-60CF69C9-95BC-47F0-B485-180EAE7659A9Q27686923-296C4C05-B6E0-49BF-8C1B-40931C2D0549Q34152074-7EAFDCC7-B930-4274-8115-A38DCC1C08F8Q34577514-1FA8D6EF-302B-4FF0-A1CA-760F7CA68A70Q35224148-BB241F71-5D30-4135-9C6E-FCEA19492FA8Q35926878-766C98B2-9C5C-4003-A41A-C93D55153CDAQ36358166-3CAFEFE7-0EE0-41A4-BFE7-C8C4F54FBA75Q36759689-254BCDE0-187C-4250-808E-EDFAE1DC5614Q37496579-50566DD0-46C7-4BE2-87A7-2A0419A31988Q38218260-7C3D4E7D-C41F-4BB6-A824-469110986024Q40218621-150AD416-2089-4734-9CFC-E370D438E25EQ40893286-111EFE4E-8F78-44A2-BC5B-4DD4DCEE65EBQ40973280-6797FFE6-2AFE-4B59-93ED-E8F1C3747774Q41671765-9D5A8DC4-68F2-4EF4-99E3-23658388C9A7Q41919495-BCB0CB47-3D57-4B1D-B392-AF2F964A81F0Q43586321-A3916D06-C203-4D4D-A974-7C9788D44D5DQ50066293-AC281740-47EB-48E6-92A6-670FFCD8C0CEQ54254238-295EF133-2D49-4A40-917E-1D4960344358Q56893551-73DD60D9-67AA-4A83-856F-74D3153A10F0Q58548875-ABA4FA3A-FA89-4E1A-BAB7-0CA30D995C14
P2860
Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Novel mechanism of antibodies ...... l particle release from cells.
@en
Novel mechanism of antibodies ...... l particle release from cells.
@nl
type
label
Novel mechanism of antibodies ...... l particle release from cells.
@en
Novel mechanism of antibodies ...... l particle release from cells.
@nl
prefLabel
Novel mechanism of antibodies ...... l particle release from cells.
@en
Novel mechanism of antibodies ...... l particle release from cells.
@nl
P2093
P2860
P356
P1433
P1476
Novel mechanism of antibodies ...... al particle release from cells
@en
P2093
Avidan U Neumann
Harel Dahari
Idit Levine
Nikolai V Naoumov
Rachel Eren
Shlomo Dagan
P2860
P304
P356
10.1002/HEP.23778
P407
P577
2010-09-01T00:00:00Z